Log in or Sign up for Free to view tailored content for your specialty!
Cardiometabolic Disorders News
Reversing CVD trends requires focus on health equity, early interventions
PHILADELPHIA — CVD trends, particularly for HF, have gotten worse since 2011, and a way to address them may be to focus on health equity and begin prevention early, a speaker said at the Heart in Diabetes CME conference.
Black patients with HF undertreated with SGLT2 inhibitors
PHILADELPHIA — Black patients are highly likely to benefit from prescription of SGLT2 inhibitors for HF, but they are less commonly prescribed them compared with other patients, according to a speaker.
Log in or Sign up for Free to view tailored content for your specialty!
Black patients with HF undertreated with SGLT2 inhibitors
PHILADELPHIA — Black patients are highly likely to benefit from prescription of SGLT2 inhibitors for HF, but they are less commonly prescribed them compared with other patients, according to a speaker.
Hybrid Heart in Diabetes conference offers ‘new twist’ on latest cardiometabolic research
Experts across the cardiorenal metabolic specialties will again convene to present innovative research on the relationship between type 2 diabetes, CVD and renal disease, including controversial debates and panel discussions.
Thyroid hormone levels linked to liver fibrosis in type 2 diabetes
Among patients with type 2 diabetes and normal thyroid function, thyroid hormone levels were linked to nonalcoholic fatty liver disease, suggesting assessment of these hormones might be beneficial for disease prevention and treatment.
Growth hormone reduces liver fat, inflammation in adults with NAFLD
ATLANTA — Adults with overweight or obesity and nonalcoholic fatty liver disease, or NAFLD, had a significant reduction in liver fat and inflammation with daily subcutaneous growth hormone administration, according to a speaker.
Lower HbA1c, blood pressure protect against CVD in type 1 diabetes
Both lower HbA1c and lower blood pressure were protective cardiovascular health metrics for adults with type 1 diabetes, according to findings published in Diabetologia.
Endocrine-disrupting chemicals elevate risk for gestational diabetes
Exposure to certain endocrine-disrupting chemicals, including polychlorinated biphenyls and polybrominated diphenyl ethers, heightened the risk for gestational diabetes in a recent study.
Empagliflozin lowers risk for kidney stones in type 2 diabetes
ATLANTA — Use of empagliflozin was associated with a nearly 40% reduced risk for nephrolithiasis among people with type 2 diabetes, according to data presented at ENDO 2022.
SGLT2 inhibition may improve CV outcomes in those with diabetes undergoing cancer therapy
In patients with diabetes and cancer treated with anthracyclines, SGLT2 inhibition was associated with fewer cardiac events during 1.5 years of follow-up, researchers reported.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read